ملف:Considerations for the design of engineered live bacterial therapeutics.pdf
![ملف:Considerations for the design of engineered live bacterial therapeutics.pdf](/w/images/thumb/7/76/Considerations_for_the_design_of_engineered_live_bacterial_therapeutics.pdf/page1-375px-Considerations_for_the_design_of_engineered_live_bacterial_therapeutics.pdf.jpg?20231007140918)
حجم معاينة JPG لذلك الملف ذي الامتداد PDF: 375 × 600 بكسل.
الملف الأصلي (750 × 1٬200 بكسل حجم الملف: 394 كيلوبايت، نوع MIME: application/pdf)
وصف قصير
⧼wm-license-information-description⧽ |
English: a Several aspects require consideration during the design of an engineered bacterial therapeutic. The selection of a chassis organism can be guided by the desired site of activity and pharmacokinetic properties of the chassis, as well as manufacturing feasibility. The design of genetic circuits may also be influenced by the circuit’s effectors, pragmatic concerns regarding inducer compounds, and the genetic stability of regulatory circuits. Critically, the design of an engineered bacterial drug may also be constrained by considerations for the needs of patients. b Optimal strain design often requires a balance between strain suitability for function in the target microenvironment and concerns for feasibility of manufacturing and clinical development.[1]
|
⧼wm-license-information-date⧽ | 2020 |
⧼wm-license-information-source⧽ | https://doi.org/10.1038/s41467-020-15508-1 |
⧼wm-license-information-author⧽ | Mark R. Charbonneau, Vincent M. Isabella, Ning Li & Caroline B. Kurtz |
ترخيص
تاريخ الملف
اضغط على زمن/تاريخ لرؤية الملف كما بدا في هذا الزمن.
زمن/تاريخ | صورة مصغرة | الأبعاد | مستخدم | تعليق | |
---|---|---|---|---|---|
حالي | ★ مراجعة معتمدة 14:09، 7 أكتوبر 2023 | ![]() | 750 × 1٬200 (394 كيلوبايت) | Pastakhov (نقاش | مساهمات) | Upload https://upload.wikimedia.org/wikipedia/commons/7/76/Considerations_for_the_design_of_engineered_live_bacterial_therapeutics.pdf |
لا يمكنك استبدال هذا الملف.
وصلات
لا يوجد صفحات تصل لهذه الصورة.